Clinical implications of an accurate problem list on heart failure treatment

Journal of General Internal Medicine

Volumn 20, Issue 2, 2005, Pages 143-147

  Hartung, Daniel M ^a   Hunt, Jacquelyn ^b,c   Siemienczuk, Joseph ^b   Miller, Heather ^b   Touchette, Daniel R ^a  

^a OR State Univ College of Pharmacy   (United States)

^b EARLE A CHILES RESEARCH INSTITUTE   (United States)

^c Providence Medical Group   (United States)

Author keywords

Drug therapy; Heart failure; Problem oriented medical records; Quality indicators

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; METOPROLOL; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; SPIRONOLACTONE; VASODILATOR AGENT;

AGED; ARTICLE; DATA BASE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; PRIMARY MEDICAL CARE; SYSTOLE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; COMMUNITY HEALTH CENTERS; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION REVIEW; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LOGISTIC MODELS; MALE; MEDICAL RECORDS, PROBLEM-ORIENTED; MIDDLE AGED; OREGON; PHYSICIAN'S PRACTICE PATTERNS; RECEPTORS, ANGIOTENSIN; RETROSPECTIVE STUDIES;

EID: 18244409610     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2005.40206.x     Document Type: Article

References (20)

1. Weed LL. Medical records that guide and teach. N Engl J Med. 1968;278:593-600.
2. Wennberg JE, Gittelsohn AM. Small area variations in health care delivery. Science. 1973;183:1102-8.
3. Chassin MR. Is health care ready for Six Sigma quality? Milbank Q. 1998;76510:565-91.
4. Eddy DM. The challenge. JAMA. 1990;263:287-90.
5. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001.
6. Simborg DW, Starfield BH, Horn SD, Yourtee SA. Information factors affecting problem follow-up in ambulatory care. Med Care. 1976;14:848-56.
7. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001;38:2101-13.
8. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure. Am J Cardiol. 1999;83:1A-38A.
9. Khalil ME, Basher AW, Brown J, Edward J, Alhaddad IA. A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients. J Am Coll Cardiol. 2001;37:1757-64.
10. Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999;100:2312-8.
11. Univasc [package insert]. Milwaukee, WI: Schwarz Pharma; 2001.
12. Lotensin [package insert]. East Hanover, NJ: Novartis; 2002.
13. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992;327:669-77.
14. McAlister FA, Teo KK, Taher M, et al. Insights into the contemporary epidemiology and outpatient management of congestive heart failure. Am Heart J. 1999;138:87-94.
15. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: Wiley-Interscience; 2000.
16. Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet. 2000;355:1575-81.
17. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-46.
18. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-55.
19. Hennekens CH, Buring JE. Epidemiology in Medicine. Boston, MA: Little, Brown and Company; 1987.
20. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44(suppl):166-206.